SUNFISH clinical trial
E1551030
UNEXPLORED
The SUNFISH clinical trial is a pivotal study evaluating the safety and efficacy of the drug risdiplam in patients with spinal muscular atrophy (SMA).
All labels observed (1)
| Label | Occurrences |
|---|---|
| SUNFISH clinical trial canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22692960 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: SUNFISH clinical trial Context triple: [FIREFISH, relatedTo, SUNFISH clinical trial]
-
A.
APHINITY trial
The APHINITY trial is a large phase III clinical study that evaluated the addition of pertuzumab (Perjeta) to standard trastuzumab-based adjuvant therapy in patients with HER2-positive early breast cancer.
-
B.
EMERGE (Study 302)
EMERGE (Study 302) is a pivotal Phase 3 clinical trial designed to evaluate the efficacy and safety of the Alzheimer’s disease drug aducanumab (Aduhelm) in patients with early-stage Alzheimer’s.
-
C.
CLEOPATRA trial
The CLEOPATRA trial was a pivotal phase III clinical study that demonstrated improved survival by adding pertuzumab (Perjeta) to trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.
-
D.
INA trials
INA trials were a series of high-profile court-martials held by the British colonial government in 1945–46 to prosecute officers and soldiers of Subhas Chandra Bose’s Indian National Army, which became a major catalyst for India’s independence movement.
-
E.
ENSEMBLE trial
The ENSEMBLE trial was a large, global Phase 3 clinical study designed to evaluate the safety and efficacy of Janssen’s single-dose COVID-19 vaccine in preventing SARS-CoV-2 infection and severe disease.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: SUNFISH clinical trial Target entity description: The SUNFISH clinical trial is a pivotal study evaluating the safety and efficacy of the drug risdiplam in patients with spinal muscular atrophy (SMA).
-
A.
APHINITY trial
The APHINITY trial is a large phase III clinical study that evaluated the addition of pertuzumab (Perjeta) to standard trastuzumab-based adjuvant therapy in patients with HER2-positive early breast cancer.
-
B.
EMERGE (Study 302)
EMERGE (Study 302) is a pivotal Phase 3 clinical trial designed to evaluate the efficacy and safety of the Alzheimer’s disease drug aducanumab (Aduhelm) in patients with early-stage Alzheimer’s.
-
C.
CLEOPATRA trial
The CLEOPATRA trial was a pivotal phase III clinical study that demonstrated improved survival by adding pertuzumab (Perjeta) to trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.
-
D.
INA trials
INA trials were a series of high-profile court-martials held by the British colonial government in 1945–46 to prosecute officers and soldiers of Subhas Chandra Bose’s Indian National Army, which became a major catalyst for India’s independence movement.
-
E.
ENSEMBLE trial
The ENSEMBLE trial was a large, global Phase 3 clinical study designed to evaluate the safety and efficacy of Janssen’s single-dose COVID-19 vaccine in preventing SARS-CoV-2 infection and severe disease.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.